Exact Mass: 459.199433
Exact Mass Matches: 459.199433
Found 138 metabolites which its exact mass value is equals to given mass value 459.199433
,
within given mass tolerance error 0.01 dalton. Try search metabolite list with more accurate mass tolerance error
0.001 dalton.
Apixaban
B - Blood and blood forming organs > B01 - Antithrombotic agents > B01A - Antithrombotic agents > B01AF - Direct factor xa inhibitors C78275 - Agent Affecting Blood or Body Fluid > C263 - Anticoagulant Agent > C173067 - Direct Factor Xa Inhibitor C78275 - Agent Affecting Blood or Body Fluid > C263 - Anticoagulant Agent > C180619 - Direct Oral Anticoagulant D004791 - Enzyme Inhibitors > D011480 - Protease Inhibitors > D015842 - Serine Proteinase Inhibitors D006401 - Hematologic Agents > D000925 - Anticoagulants > D000991 - Antithrombins COVID info from clinicaltrial, clinicaltrials, clinical trial, clinical trials Corona-virus Coronavirus SARS-CoV-2 COVID-19 SARS-CoV COVID19 SARS2 SARS
2-[(1S,2S,4R)-2-Hydroxy-7,7-dimethyl-1-(spiro[indene-1,4'-piperidine]-1'-ylsulfonylmethyl)-2-bicyclo[2.2.1]heptanyl]acetic acid
C25H33NO5S (459.2079328000001)
Apixaban
B - Blood and blood forming organs > B01 - Antithrombotic agents > B01A - Antithrombotic agents > B01AF - Direct factor xa inhibitors C78275 - Agent Affecting Blood or Body Fluid > C263 - Anticoagulant Agent > C173067 - Direct Factor Xa Inhibitor C78275 - Agent Affecting Blood or Body Fluid > C263 - Anticoagulant Agent > C180619 - Direct Oral Anticoagulant D004791 - Enzyme Inhibitors > D011480 - Protease Inhibitors > D015842 - Serine Proteinase Inhibitors D006401 - Hematologic Agents > D000925 - Anticoagulants > D000991 - Antithrombins COVID info from clinicaltrial, clinicaltrials, clinical trial, clinical trials Corona-virus Coronavirus SARS-CoV-2 COVID-19 SARS-CoV COVID19 SARS2 SARS
rel-(5aR,6R,12S,14aR)-12-[(1R)-1,2-dihydroxy-2-methylpropyl]-1,2,3,5a,6,11,12,14a-octahydro-5a-hydroxy-6,9-dimethoxy-5H,14H-pyrrolo[1,2:4,5]pyrazino[1,2:1,6]pyrido[3,4-b]indole-5,14-dione|rel-(8S,19S)-19,20-dihydro-9,19,20-trihydroxy-8-methoxy-9-epi-fumitremorgin C
Ala Asn Gln Gln
Ala Gln Asn Gln
Ala Gln Gln Asn
Asp Pro Gln Thr
C18H29N5O9 (459.19651840000006)
Asp Pro Thr Gln
C18H29N5O9 (459.19651840000006)
Asp Gln Pro Thr
C18H29N5O9 (459.19651840000006)
Asp Gln Thr Pro
C18H29N5O9 (459.19651840000006)
Asp Thr Pro Gln
C18H29N5O9 (459.19651840000006)
Asp Thr Gln Pro
C18H29N5O9 (459.19651840000006)
Glu Asn Pro Thr
C18H29N5O9 (459.19651840000006)
Glu Asn Thr Pro
C18H29N5O9 (459.19651840000006)
Glu Pro Asn Thr
C18H29N5O9 (459.19651840000006)
Glu Pro Gln Ser
C18H29N5O9 (459.19651840000006)
Glu Pro Ser Gln
C18H29N5O9 (459.19651840000006)
Glu Pro Thr Asn
C18H29N5O9 (459.19651840000006)
Glu Gln Pro Ser
C18H29N5O9 (459.19651840000006)
Glu Gln Ser Pro
C18H29N5O9 (459.19651840000006)
Glu Ser Pro Gln
C18H29N5O9 (459.19651840000006)
Glu Ser Gln Pro
C18H29N5O9 (459.19651840000006)
Glu Thr Asn Pro
C18H29N5O9 (459.19651840000006)
Glu Thr Pro Asn
C18H29N5O9 (459.19651840000006)
Gly Gln Gln Gln
Asn Ala Gln Gln
Asn Glu Pro Thr
C18H29N5O9 (459.19651840000006)
Asn Glu Thr Pro
C18H29N5O9 (459.19651840000006)
Asn Asn Asn Val
Asn Asn Val Asn
Asn Pro Glu Thr
C18H29N5O9 (459.19651840000006)
Asn Pro Thr Glu
C18H29N5O9 (459.19651840000006)
Asn Gln Ala Gln
Asn Gln Gln Ala
Asn Thr Glu Pro
C18H29N5O9 (459.19651840000006)
Asn Thr Pro Glu
C18H29N5O9 (459.19651840000006)
Asn Val Asn Asn
Pro Asp Gln Thr
C18H29N5O9 (459.19651840000006)
Pro Asp Thr Gln
C18H29N5O9 (459.19651840000006)
Pro Glu Asn Thr
C18H29N5O9 (459.19651840000006)
Pro Glu Gln Ser
C18H29N5O9 (459.19651840000006)
Pro Glu Ser Gln
C18H29N5O9 (459.19651840000006)
Pro Glu Thr Asn
C18H29N5O9 (459.19651840000006)
Pro Asn Glu Thr
C18H29N5O9 (459.19651840000006)
Pro Asn Thr Glu
C18H29N5O9 (459.19651840000006)
Pro Gln Asp Thr
C18H29N5O9 (459.19651840000006)
Pro Gln Glu Ser
C18H29N5O9 (459.19651840000006)
Pro Gln Ser Glu
C18H29N5O9 (459.19651840000006)
Pro Gln Thr Asp
C18H29N5O9 (459.19651840000006)
Pro Ser Glu Gln
C18H29N5O9 (459.19651840000006)
Pro Ser Gln Glu
C18H29N5O9 (459.19651840000006)
Pro Thr Asp Gln
C18H29N5O9 (459.19651840000006)
Pro Thr Glu Asn
C18H29N5O9 (459.19651840000006)
Pro Thr Asn Glu
C18H29N5O9 (459.19651840000006)
Pro Thr Gln Asp
C18H29N5O9 (459.19651840000006)
Gln Ala Asn Gln
Gln Ala Gln Asn
Gln Asp Pro Thr
C18H29N5O9 (459.19651840000006)
Gln Asp Thr Pro
C18H29N5O9 (459.19651840000006)
Gln Glu Pro Ser
C18H29N5O9 (459.19651840000006)
Gln Glu Ser Pro
C18H29N5O9 (459.19651840000006)
Gln Gly Gln Gln
Gln Asn Ala Gln
Gln Asn Gln Ala
Gln Pro Asp Thr
C18H29N5O9 (459.19651840000006)
Gln Pro Glu Ser
C18H29N5O9 (459.19651840000006)
Gln Pro Ser Glu
C18H29N5O9 (459.19651840000006)
Gln Pro Thr Asp
C18H29N5O9 (459.19651840000006)
Gln Gln Ala Asn
Gln Gln Gly Gln
Gln Gln Asn Ala
Gln Gln Gln Gly
Gln Ser Glu Pro
C18H29N5O9 (459.19651840000006)
Gln Ser Pro Glu
C18H29N5O9 (459.19651840000006)
Gln Thr Asp Pro
C18H29N5O9 (459.19651840000006)
Gln Thr Pro Asp
C18H29N5O9 (459.19651840000006)
Ser Glu Pro Gln
C18H29N5O9 (459.19651840000006)
Ser Glu Gln Pro
C18H29N5O9 (459.19651840000006)
Ser Pro Glu Gln
C18H29N5O9 (459.19651840000006)
Ser Pro Gln Glu
C18H29N5O9 (459.19651840000006)
Ser Gln Glu Pro
C18H29N5O9 (459.19651840000006)
Ser Gln Pro Glu
C18H29N5O9 (459.19651840000006)
Thr Asp Pro Gln
C18H29N5O9 (459.19651840000006)
Thr Asp Gln Pro
C18H29N5O9 (459.19651840000006)
Thr Glu Asn Pro
C18H29N5O9 (459.19651840000006)
Thr Glu Pro Asn
C18H29N5O9 (459.19651840000006)
Thr Asn Glu Pro
C18H29N5O9 (459.19651840000006)
Thr Asn Pro Glu
C18H29N5O9 (459.19651840000006)
Thr Pro Asp Gln
C18H29N5O9 (459.19651840000006)
Thr Pro Glu Asn
C18H29N5O9 (459.19651840000006)
Thr Pro Asn Glu
C18H29N5O9 (459.19651840000006)
Thr Pro Gln Asp
C18H29N5O9 (459.19651840000006)
Thr Gln Asp Pro
C18H29N5O9 (459.19651840000006)
Thr Gln Pro Asp
C18H29N5O9 (459.19651840000006)
Val Asn Asn Asn
2-(2-ethoxy-5-piperidin-1-ylsulfonylphenyl)-5-methyl-7-propyl-1H-imidazo[5,1-f][1,2,4]triazin-4-one
C22H29N5O4S (459.19401540000007)
(3S,4S)-TERT-BUTYL 3-ETHOXY-4-(2-(3-(TRIFLUOROMETHYL)BENZAMIDO)ACETAMIDO)PYRROLIDINE-1-CARBOXYLATE
C21H28F3N3O5 (459.19809540000006)
Fluazacort
C147908 - Hormone Therapy Agent > C548 - Therapeutic Hormone > C1636 - Therapeutic Steroid Hormone C308 - Immunotherapeutic Agent > C574 - Immunosuppressant > C211 - Therapeutic Corticosteroid
3-N-FMOC-AMINO-3-(2-T-BUTOXYPHENYL)PROPIONIC ACID
C28H29NO5 (459.20456240000004)
3-N-FMOC-AMINO-3-(3-T-BUTOXYPHENYL)PROPIONIC ACID
C28H29NO5 (459.20456240000004)
1-[(4-fluorophenyl)methyl]-N-[4-(4-methyl-1-piperazinyl)phenyl]-2-oxo-3H-benzimidazole-5-carboxamide
(6R,7R,8R)-N-(3-fluorophenyl)-8-(hydroxymethyl)-7-[4-(2-methylphenyl)phenyl]-2-oxo-1,4-diazabicyclo[4.2.0]octane-4-carboxamide
1-(2,5-difluorophenyl)-3-[(2R,3S,6R)-6-[2-(3,4-dihydro-1H-isoquinolin-2-yl)-2-oxoethyl]-2-(hydroxymethyl)oxan-3-yl]urea
C24H27F2N3O4 (459.1969526000001)
1-(2,5-difluorophenyl)-3-[(2S,3R,6S)-6-[2-(3,4-dihydro-1H-isoquinolin-2-yl)-2-oxoethyl]-2-(hydroxymethyl)oxan-3-yl]urea
C24H27F2N3O4 (459.1969526000001)
1-(2,5-difluorophenyl)-3-[(2S,3R,6R)-6-[2-(3,4-dihydro-1H-isoquinolin-2-yl)-2-oxoethyl]-2-(hydroxymethyl)-3-oxanyl]urea
C24H27F2N3O4 (459.1969526000001)
1-(2,5-difluorophenyl)-3-[(2S,3S,6R)-6-[2-(3,4-dihydro-1H-isoquinolin-2-yl)-2-oxoethyl]-2-(hydroxymethyl)-3-oxanyl]urea
C24H27F2N3O4 (459.1969526000001)
1-(2,5-difluorophenyl)-3-[(2R,3S,6S)-6-[2-(3,4-dihydro-1H-isoquinolin-2-yl)-2-oxoethyl]-2-(hydroxymethyl)-3-oxanyl]urea
C24H27F2N3O4 (459.1969526000001)
1-(2,5-difluorophenyl)-3-[(2R,3R,6S)-6-[2-(3,4-dihydro-1H-isoquinolin-2-yl)-2-oxoethyl]-2-(hydroxymethyl)-3-oxanyl]urea
C24H27F2N3O4 (459.1969526000001)
(2R,3R,3aS,9bS)-2-[3,4-dihydro-1H-isoquinolin-2-yl(oxo)methyl]-7-(2-fluorophenyl)-3-(hydroxymethyl)-1,2,3,3a,4,9b-hexahydropyrrolo[2,3-a]indolizin-6-one
[(1R)-7-methoxy-2-methyl-1-[(1-methyl-4-imidazolyl)sulfonyl]-1-spiro[3,9-dihydro-1H-pyrido[3,4-b]indole-4,4-piperidine]yl]methanol
C22H29N5O4S (459.19401540000007)
[(1S)-7-methoxy-2-methyl-1-[(1-methyl-4-imidazolyl)sulfonyl]-1-spiro[3,9-dihydro-1H-pyrido[3,4-b]indole-4,4-piperidine]yl]methanol
C22H29N5O4S (459.19401540000007)
(6S,7S,8R)-N-(3-fluorophenyl)-8-(hydroxymethyl)-7-[4-(2-methylphenyl)phenyl]-2-oxo-1,4-diazabicyclo[4.2.0]octane-4-carboxamide
1-(2,5-difluorophenyl)-3-[(2S,3S,6S)-6-[2-(3,4-dihydro-1H-isoquinolin-2-yl)-2-oxoethyl]-2-(hydroxymethyl)-3-oxanyl]urea
C24H27F2N3O4 (459.1969526000001)
1-(2,5-difluorophenyl)-3-[(2R,3R,6R)-6-[2-(3,4-dihydro-1H-isoquinolin-2-yl)-2-oxoethyl]-2-(hydroxymethyl)-3-oxanyl]urea
C24H27F2N3O4 (459.1969526000001)
(2S,3S,3aR,9bR)-2-[3,4-dihydro-1H-isoquinolin-2-yl(oxo)methyl]-7-(2-fluorophenyl)-3-(hydroxymethyl)-1,2,3,3a,4,9b-hexahydropyrrolo[2,3-a]indolizin-6-one
(6S,7S,8S)-N-(3-fluorophenyl)-8-(hydroxymethyl)-7-[4-(2-methylphenyl)phenyl]-2-oxo-1,4-diazabicyclo[4.2.0]octane-4-carboxamide
(6R,7R,8S)-N-(3-fluorophenyl)-8-(hydroxymethyl)-7-[4-(2-methylphenyl)phenyl]-2-oxo-1,4-diazabicyclo[4.2.0]octane-4-carboxamide
CZ415
C22H29N5O4S (459.19401540000007)
CZ415 is a potent and highly selective mTOR inhibitor with a pIC50 of 8.07. CZ415 inhibits mTORC1 and mTORC2 protein complex. CZ415 is a potent and highly selective mTOR inhibitor with a pIC50 of 8.07. CZ415 inhibits mTORC1 and mTORC2 protein complex.
IDH1 Inhibitor 7
IDH1 Inhibitor 7 (Compound 88) is an IDH1 inhibitor with an IC50 of less than 100 nM[1].